TruSpine Technologies PLC - London Gatwick Airport-based medical device company - At Friday's annual general meeting, company discloses that advanced discussions are currently underway with several potential commercial strategic partners. But pledges not to provide a running commentary on regulatory discussions. Believes this can be misinterpreted and, or seen as pre-empting a regulatory decision. Vows to improve communication with shareholders. Chair Geoff Miller says: "My enthusiasm for the potential of the business is greater than ever."

Current stock price: 3.25 pence, up 10% in London on Friday

12-month change: more than trebled

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.